Roasted Oolong Tea Shows Anti-Aging Liver Protection in Mice via NF-κB Pathway

A cup of roasted oolong tea may do far more than deliver a pleasant caramel aroma. A new study published in Food Science & Nutrition reports that Nongxiang-type Tieguanyin, a heavily roasted oolong from Anxi in China’s Fujian Province, protected the livers of aging mice from oxidative damage, fibrosis, and cellular senescence. The researchers traced the effect to a specific molecular target: the NF-κB signaling pathway, a pro-inflammatory cascade long implicated in the biology of aging. The finding positions a familiar traditional beverage as a candidate natural anti-aging agent and offers one of the clearest mechanistic accounts yet of how roasting may transform the bioactivity of oolong tea.

The team began by dissecting the chemistry of the roasted tea. Using colorimetric assays and high-performance liquid chromatography, they quantified the major constituents of the extract. Tea polyphenols dominated at roughly 287 milligrams per gram, followed by catechins at about 138 milligrams per gram, with tea polysaccharides, caffeine, and free amino acids rounding out the profile. Among individual catechins measured against authentic standards, EGCG led at 7.959 milligrams per gram, with catechin, catechin gallate, epigallocatechin, and gallic acid also present in appreciable amounts. Roasting, the authors note, does not merely add flavor; it restructures the active compound inventory, creating the material basis for the tea’s antioxidant, anti-inflammatory, and metabolic effects.

To test whether these compounds could counter aging, the researchers turned to a widely used model in which mice receive daily injections of D-galactose, a sugar that accumulates in tissues and drives oxidative stress, inflammation, and senescence-like damage. Male C57BL/6 mice were divided into four groups of ten: a control group receiving saline, a model group receiving D-galactose alone, and two treatment groups receiving D-galactose plus Nongxiang-type Tieguanyin extract by gavage at either 110 or 550 milligrams per kilogram per day for eight weeks. The doses were not arbitrary. The low dose was scaled from the typical daily tea consumption of Chinese adults, roughly five grams of dry leaves, using standard allometric conversion, while the high dose was set fivefold higher to probe dose dependence.

The behavioral results were striking. D-galactose-treated mice showed sharply reduced endurance on a treadmill, covering less distance before reaching exhaustion, and they faltered earlier on a rotating-rod fatigue test. High-dose tea extract reversed both deficits in a concentration-dependent manner. Grip strength, however, was unaffected, suggesting the compound acts on fatigue and metabolic capacity rather than raw muscle power. Metabolic cage measurements added a circadian dimension: D-galactose suppressed the mice’s 24-hour energy expenditure, with the loss concentrated in the dark phase when rodents are normally most active. High-dose Tieguanyin restored dark-phase energy expenditure to near-normal levels, hinting that the tea helps normalize the daily rhythm of metabolism that frays with age.

The liver emerged as the clear beneficiary. The elevated liver-to-body weight ratio caused by D-galactose fell back toward control values after tea treatment, while the heart, lungs, and kidneys showed no significant changes, indicating a liver-targeted effect. Serum levels of alanine aminotransferase and aspartate aminotransferase, the classic enzymes that spill into blood when hepatocytes are damaged, dropped in treated animals. Inside the liver, the chemical picture shifted just as decisively: levels of the antioxidant enzymes superoxide dismutase and glutathione, depleted by D-galactose, rebounded, while malondialdehyde, a marker of lipid peroxidation, declined. The authors suggest the liver’s own transport machinery may explain this selectivity, since hepatocytes actively take up tea polyphenols through organic anion-transporting polypeptides, concentrating the protective compounds where they are needed most.

Under the microscope, the damage and the rescue were both visible. Hematoxylin-eosin staining revealed that D-galactose had disrupted the architecture of hepatic lobules, disorganized hepatocytes, and loosened cytoplasm, abnormalities that tea treatment largely corrected. Masson staining, which dyes collagen blue, showed extensive fibrous proliferation in the aged livers that receded with treatment, and the fibrosis marker alpha-SMA fell in parallel at the protein level. Senescence itself left a measurable fingerprint: beta-galactosidase staining, a hallmark of senescent cells, lit up the D-galactose livers but faded with tea intervention. Western blotting completed the picture, showing that the senescence drivers P16, P21, and P53, which D-galactose had upregulated, were dialed back, while Sirt1, a longevity-associated deacetylase that D-galactose had suppressed, was restored.

To confirm the effect was not a rodent quirk, the team ran parallel experiments in cultured cells. They induced senescence in AML12 mouse hepatocytes and HepG2 human liver cancer cells using Nutlin-3a, a drug that activates p53-dependent senescence pathways. Co-treatment with the tea extract at one milligram per milliliter significantly reduced p16 and p21 protein levels in both cell lines and cut the fraction of blue-stained, senescence-positive cells. The consistency across mouse and human liver-derived cells strengthens the case that the anti-senescence activity is a genuine biological property of the extract rather than an artifact of one species or one model.

The mechanistic core of the study came from transcriptomics. Sequencing liver RNA revealed 1604 differentially expressed genes between D-galactose and control mice, and 3046 between D-galactose and high-dose tea mice, with 216 genes overlapping. Enrichment analyses converged on a single pathway: NF-κB, the master regulator of inflammatory transcription, was significantly activated by D-galactose and reversed by tea treatment. Gene set enrichment analysis confirmed the pattern, and western blots supplied the protein-level proof. D-galactose specifically increased the phosphorylation of the IKKα/β complex and of the p65 subunit, the molecular switch that releases NF-κB to enter the nucleus and ignite inflammatory gene expression. Tea extract suppressed both phosphorylation events in a dose-dependent fashion, while total protein levels stayed constant.

The authors frame this suppression as a direct counter to inflammaging, the chronic, low-grade inflammation that accompanies aging. Reactive oxygen species generated by dysfunctional mitochondria can activate the IKK complex through upstream kinases such as TAK1, and the tea’s restoration of antioxidant defenses likely starves that cascade of its trigger. The concurrent rise in Sirt1 adds a second brake, since Sirt1 can deacetylate p65 and dampen its transcriptional activity. The researchers are candid about limits: the D-galactose model captures oxidative stress-driven aging rather than the full complexity of natural senescence, and the cell experiments validated the phenotype rather than the upstream NF-κB axis, leaving causal validation for future work with naturally aged animals.

Even so, the translational arithmetic is tantalizing. The low mouse dose corresponds to about five grams of dry roasted Tieguanyin per day for a sixty-kilogram person, squarely within ordinary tea-drinking habits, while the high dose, equivalent to roughly twenty-five grams, could be reached through concentrated extracts or supplements. The authors envision the tea evolving from a traditional beverage into a functional food or anti-aging agent, pending clinical trials to confirm efficacy and optimal dosing in humans. For now, the study delivers something rarer than a health claim: a defined molecular pathway, verified at the levels of behavior, biochemistry, histology, transcriptome, and protein, through which a roasted oolong appears to slow the aging liver’s decline.

Subject of Research: Hepatoprotective and anti-senescence effects of roasted oolong tea extract in a D-galactose mouse aging model mediated by NF-κB pathway inhibition

Article Title: Protective Effects of Nongxiang‐Type Tieguanyin on the Liver of D‐Galactose‐Induced Aging C57BL/6 Mice via the NF‐κB Signaling Pathway

Article References: Chen, W., Li, M., Ye, L., Huang, D., Xiao, J., Sang, Y., Wang, Z., Yang, J., He, C., Chen, J., Zuo, Z., & Chen, X. (2026). Protective Effects of Nongxiang‐Type Tieguanyin on the Liver of D‐Galactose‐Induced Aging C57BL /6 Mice via the NF ‐ κB Signaling Pathway. Food Science & Nutrition, 14(10), Article e72396. https://doi.org/10.1002/fsn3.72396

Image Credits: AI Generated

DOI: 10.1002/fsn3.72396

Keywords: Tieguanyin, oolong tea, NF-κB signaling, liver aging, D-galactose, oxidative stress, cellular senescence, Sirt1, hepatic fibrosis, tea polyphenols, inflammaging, C57BL/6 mice